Methylprednisolone (Solu-Medrol) — Clinical FAQs

Question 1

What is Methylprednisolone FDA-approved to treat?

Accepted Answer

Methylprednisolone is FDA-approved for the following oncology indications: 1. Palliative management of leukemias and lymphomas in adults (broad corticosteroid oncology labeling) 2. Acute exacerbations of inflammatory, allergic, and autoimmune conditions 3. Cerebral edema associated with brain tumors (adjunctive) 4. Adrenocortical insufficiency and a wide range of endocrine, rheumatic, and hematologic disorders (broad FDA labeling).

Question 2

How does Methylprednisolone work (mechanism of action)?

Accepted Answer

Methylprednisolone is an intermediate-acting synthetic glucocorticoid with roughly 5 times the anti-inflammatory potency of hydrocortisone and negligible mineralocorticoid activity. It binds the cytoplasmic glucocorticoid receptor (GR-α); the activated ligand-receptor complex translocates to the nucleus to modulate transcription via glucocorticoid response elements, suppressing NF-κB-driven pro-inflammatory cytokine synthesis (IL-1, IL-2, IL-6, TNF-α) and inducing apoptosis in lymphoid cells through upregulation of pro-apoptotic mediators and downregulation of BCL-2. In salvage lymphoma regimens the high-dose glucocorticoid contributes direct lymphocytolytic activity, while its anti-edema and anti-emetic effects support tolerability of concurrent cytotoxics.

Question 3

How is Methylprednisolone administered?

Accepted Answer

Methylprednisolone is administered Intravenous (IV) or Oral (PO) or Intramuscular (IM). Highly indication-specific.

Question 4

What are the most common side effects of Methylprednisolone?

Accepted Answer

The most commonly reported side effects of Methylprednisolone (≥10% incidence) include: Hyperglycemia and glucose intolerance, Insomnia and mood disturbances (euphoria, irritability, anxiety), Increased appetite and weight gain, Fluid retention and edema, Hypertension and others (8 total). Consult your oncologist for complete prescribing information.

Question 5

Is Methylprednisolone safe during pregnancy?

Accepted Answer

Methylprednisolone pregnancy safety: Category C — glucocorticoids are teratogenic in animals (cleft palate). Short courses in oncologic indications may be warranted; neonates exposed near delivery should be monitored for adrenal insufficiency.. Oncologists should review the complete prescribing information and discuss reproductive risks with patients before initiating therapy.

Methylprednisolone — Drug Monograph

Mechanism of Action

FDA Indications

Common Side Effects

Clinical Pearl

Related Therapies & Mechanisms